{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:37:03Z","timestamp":1790041023615,"version":"4.0.1"},"reference-count":36,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,4,9]],"date-time":"2023-04-09T00:00:00Z","timestamp":1680998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the President of Nanfang Hospital of Southern Medical University","award":["2021A006"],"award-info":[{"award-number":["2021A006"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Skin cutaneous melanoma (SKCM) is a highly malignant and aggressive cancer. Previous studies have shown that cellular senescence is a promising therapeutic strategy to limit melanoma cell progression. However, models to predict the prognosis of melanoma based on senescence-related lncRNAs and the efficacy of immune checkpoint therapy remain undefined. In this study, we developed a predictive signature consisting of four senescence-related lncRNAs (AC009495.2, U62317.1, AATBC, MIR205HG), and we then classified patients into high- and low-risk groups. GSEA (Gene set enrichment analysis) showed different activation of immune-related pathways in two groups. In addition, there were significant differences between the scores of tumor immune microenvironment, tumor burden mutation, immune checkpoint expression, and chemotherapeutic drug sensitivity between the two groups of patients. It provides new insights to guide more personalized treatment for patients with SKCM.<\/jats:p>","DOI":"10.3390\/biom13040661","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T03:26:06Z","timestamp":1681097166000},"page":"661","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Senescence-Related lncRNA Signature Predicts Prognosis, Response to Immunotherapy and Chemotherapy in Skin Cutaneous Melanoma"],"prefix":"10.3390","volume":"13","author":[{"given":"Kefan","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingtong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Chen","sequence":"additional","affiliation":[{"name":"First Clinical Medical College, Southern Medical University, Guangzhou 510515, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longmei","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-pathol-012513-104658","article-title":"The Molecular Pathology of Melanoma: An Integrated Taxonomy of Melanocytic Neoplasia","volume":"9","author":"Bastian","year":"2014","journal-title":"Annu. Rev. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1056\/NEJMsb2019760","article-title":"The Rapid Rise in Cutaneous Melanoma Diagnoses","volume":"384","author":"Welch","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jso.21962","article-title":"Evidence-Based Treatment of Early-Stage Melanoma","volume":"104","author":"Ross","year":"2011","journal-title":"J. Surg. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1038\/s41467-020-15546-9","article-title":"Pre-Clinical Modeling of Cutaneous Melanoma","volume":"11","author":"Rebecca","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1002\/1878-0261.12807","article-title":"Cellular Senescence in Cancer: From Mechanisms to Detection","volume":"15","author":"Ou","year":"2021","journal-title":"Mol. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrm3823","article-title":"Cellular Senescence: From Physiology to Pathology","volume":"15","author":"Serrano","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1152\/physrev.00020.2018","article-title":"Cellular Senescence: Aging, Cancer, and Injury","volume":"99","author":"Calcinotto","year":"2019","journal-title":"Physiol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1101\/gad.343129.120","article-title":"Senescence and the SASP: Many Therapeutic Avenues","volume":"34","author":"Birch","year":"2020","journal-title":"Genes Dev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","article-title":"Long Non-Coding RNA (LncRNA) and Cancer: A New Paradigm","volume":"77","author":"Bhan","year":"2017","journal-title":"Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fgene.2019.00292","article-title":"Identification of Long Non-Coding and Messenger RNAs Differentially Expressed Between Primary and Metastatic Melanoma","volume":"10","author":"Sun","year":"2019","journal-title":"Front. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"935056","DOI":"10.3389\/fgene.2022.935056","article-title":"Identification and Validation of a Novel Cellular Senescence-Related LncRNA Prognostic Signature for Predicting Immunotherapy Response in Stomach Adenocarcinoma","volume":"13","author":"Zeng","year":"2022","journal-title":"Front. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.21037\/jgo-22-721","article-title":"A Novel Senescence-Associated LncRNA Signature Predicts the Prognosis and Tumor Microenvironment of Patients with Colorectal Cancer: A Bioinformatics Analysis","volume":"13","author":"Huang","year":"2022","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"20684","DOI":"10.18632\/aging.203455","article-title":"Construction of an Immune-Related LncRNA Signature as a Novel Prognosis Biomarker for LUAD","volume":"13","author":"Chen","year":"2021","journal-title":"Aging"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) Hallmark Gene Set Collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma Powers Differential Expression Analyses for RNA-Sequencing and Microarray Studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nbt0308-303","article-title":"What Is Principal Component Analysis?","volume":"26","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for Analysis of Tumor-Infiltrating Immune Cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling Tumor Infiltrating Immune Cells with CIBERSORT","volume":"1711","author":"Chen","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring Tumour Purity and Stromal and Immune Cell Admixture from Expression Data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: Efficient and Comprehensive Analysis of Somatic Variants in Cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT Signaling Pathway: From Bench to Clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Profit\u00f3s-Pelej\u00e0, N., Santos, J.C., Mar\u00edn-Niebla, A., Rou\u00e9, G., and Ribeiro, M.L. (2022). Regulation of B-Cell Receptor Signaling and Its Therapeutic Relevance in Aggressive B-Cell Lymphomas. Cancers, 14.","DOI":"10.3390\/cancers14040860"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41392-021-00823-w","article-title":"T Cell Receptor (TCR) Signaling in Health and Disease","volume":"6","author":"Shah","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.trecan.2016.02.004","article-title":"The Immune Biology of Microsatellite-Unstable Cancer","volume":"2","author":"Kloor","year":"2016","journal-title":"Trends Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41556-018-0249-2","article-title":"The Dynamic Nature of Senescence in Cancer","volume":"21","author":"Lee","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41568-022-00450-9","article-title":"Exploiting Senescence for the Treatment of Cancer","volume":"22","author":"Wang","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5582920","DOI":"10.1155\/2021\/5582920","article-title":"Gene Instability-Related LncRNA Prognostic Model of Melanoma Patients via Machine Learning Strategy","volume":"2021","author":"Yan","year":"2021","journal-title":"J. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.18632\/aging.202450","article-title":"LncRNA MIR205HG Regulates Melanomagenesis via the MiR-299-3p\/VEGFA Axis","volume":"13","author":"Guo","year":"2021","journal-title":"Aging"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"13097","DOI":"10.2147\/OTT.S286627","article-title":"LncRNA MIR205HG Drives Esophageal Squamous Cell Carcinoma Progression by Regulating MiR-214\/SOX4 Axis","volume":"13","author":"Li","year":"2020","journal-title":"Onco Targets Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.2147\/IJGM.S340025","article-title":"Identification and Construction of a Predictive Immune-Related LncRNA Signature Model for Melanoma","volume":"14","author":"Li","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"895200","DOI":"10.3389\/fgene.2022.895200","article-title":"An Immune-Related Long Noncoding RNA Pair as a New Biomarker to Predict the Prognosis of Patients in Breast Cancer","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Genet."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"107753","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor Microenvironment as a Therapeutic Target in Cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11912-008-0067-y","article-title":"Melanoma and the Tumor Microenvironment","volume":"10","author":"Villanueva","year":"2008","journal-title":"Curr. Oncol. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41577-021-00537-8","article-title":"CD8+ T Cell Metabolism in Infection and Cancer","volume":"21","author":"Scharping","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"888713","DOI":"10.3389\/fimmu.2022.888713","article-title":"Shaping Polarization of Tumor-Associated Macrophages In Cancer Immunotherapy","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-020-0160-6","article-title":"Immune-Related Adverse Events of Checkpoint Inhibitors","volume":"6","author":"Brahmer","year":"2020","journal-title":"Nat. Rev. Dis. Primers"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/4\/661\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:12:42Z","timestamp":1760123562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/4\/661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,9]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["biom13040661"],"URL":"https:\/\/doi.org\/10.3390\/biom13040661","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,9]]}}}